Adherence with urate-lowering therapies for the treatment of gout. - Wikidata - awgldk - TriplyDB

Adherence with urate-lowering therapies for the treatment of gout.

Adherence with urate-lowering therapies for the treatment of gout.

http://www.wikidata.org/entity/Q37206942

about

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia Gout: optimizing treatment to achieve a disease cure Medication adherence in gout: a systematic review Allopurinol: insights from studies of dose-response relationships.Patients' knowledge and beliefs concerning gout and its treatment: a population based study.The dynamics of chronic gout treatment: medication gaps and return to therapy Health care utilization in patients with gout: a prospective multicenter cohort study 2011 recommendations for the diagnosis and management of gout and hyperuricemia.Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout.Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies.Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting.Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study The pharmacokinetics of oxypurinol in people with gout.Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system Predictors of medication non-adherence for vasculitis patients Poorly controlled gout: who is doing poorly?Improving treatment adherence in patients with rheumatologic disease.Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.Utility of the Morisky Medication Adherence Scale in gout: a prospective study.Factors associated with initiation and persistence of urate-lowering therapy.Managing your patient with gout: a review of treatment options.Difficult-to-treat gouty arthritis: a disease warranting better management.Recent advances in management of gout.Hyperuricemia and gout: new concepts in diagnosis and management.Prophylaxis for acute gout flares after initiation of urate-lowering therapy.Management of gout in general practice--a systematic review.Advances in pharmacotherapy for the treatment of gout.Investigational drugs for hyperuricemia.Gouty arthropathy: Review of clinico-pathologic and imaging features.Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.Factors influencing medication adherence in patients with gout: A descriptive correlational study.Target Serum Urate: Do Gout Patients Know Their Goal?Management of gout in the real world: current practice versus guideline recommendations.A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.Gout Self-Management in African-American Veterans: A Qualitative Exploration of Challenges and Solutions from Patients' Perspectives.Education Preferences of People with Gout: Exploring Differences Between Indigenous and Non-Indigenous Peoples from Rural and Urban Locations.Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting.Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.

P2860

Q24612292-65F4A42F-4C76-414D-80E9-A8D731DCDB99 Q26765550-5D8BA4BC-12DB-4466-9323-B651DF276DC6 Q27694691-8A997162-84E4-4652-9A13-503D0996FEC9 Q30240163-47BADF8D-848D-4013-ACA7-41191BFB0439 Q31096665-29A93D56-B64E-43E0-9108-E0762688081C Q33617747-D8EF517E-F2FF-4FB2-856C-2EDDC5215952 Q33750100-34807CBA-FC26-4317-B388-5F775851BA3D Q34250995-352DC29D-458C-4272-B56B-074DAEFCDCCE Q34415029-65C1E6DB-84B1-402F-B7AB-E012BFC15588 Q34502543-ABDEA324-384C-4608-B01E-D2A93E9351F6 Q35503271-85BC032A-38F8-4840-8C07-53A6900721D5 Q35595259-38C2787F-A560-443C-BABE-E7EFB34E0753 Q35849062-F02AE6C5-77C0-45F6-AD70-D180503857E4 Q35873062-48B7B541-50D7-4FB1-9231-19BE3C4C0458 Q36336035-9797B2F8-2DB7-4BA8-B7B8-18AEE550167E Q37041741-AF0D00EC-837E-415A-874C-73A1B5CB6563 Q37094772-F64F8A7B-760C-40BC-88A1-9BAF1B9EBF5E Q37195376-E04BA9F0-4946-471A-8A2C-C9B03218AD1C Q37196980-8D93493A-4915-419D-A88D-412AA9B75B3A Q37353448-C5EBFB3E-99EF-4DAA-8ACA-2EF758988321 Q37485303-C82DC2CA-00EA-4CBF-925D-930120A09555 Q37589104-0535B866-BB4F-43F3-AABB-EA50068D166B Q37874889-745E6392-600D-4E97-ACB0-63EE40E75325 Q37910901-F8BB7D92-F61C-43D4-A06E-665F1863B540 Q37971360-EF833B73-A7F8-4D47-89DA-822485F02DE7 Q38074338-F336E7A3-0CCE-46A0-A369-1209C414F223 Q38206603-7FC11EBF-041B-41C3-A9CD-ED56F9C2DA46 Q38249921-5658BCD8-4199-40C8-A968-74ACB375EC36 Q38303416-0A3EEFD3-3B32-4C18-9151-49A395D8F682 Q38527441-CC604090-B976-4ADF-A9E9-C73D8D6853BA Q38599956-7F72A337-B141-4177-8E1A-719B96B63BBE Q38669137-27D724C0-AD9E-4861-B5D6-BC4649DFEAC3 Q38670679-AA883F27-059C-4D13-AB1F-C160D0028C6F Q40089909-38F95F44-F8BF-464D-8D1C-2E8A2D4B659D Q40291328-46A6EC68-8A33-4B7A-9FF3-10878A7C29DA Q40311349-419275B7-1CBD-4B7E-8646-3934FDF7947C Q40366290-43EE8B76-9D90-422E-B272-DE0DEF864052 Q40465860-AD146120-5F2E-42C7-9904-6153245234FB Q40770483-46CDB7DC-D394-4008-A025-FD7F28603CA0 Q41174839-E6AD4772-EF63-4D16-BF09-0307397ECA4A

P2860

Adherence with urate-lowering therapies for the treatment of gout.

http://www.wikidata.org/entity/Q37206942

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adherence with urate-lowering therapies for the treatment of gout.

@en

Adherence with urate-lowering therapies for the treatment of gout.

@nl

type

label

Adherence with urate-lowering therapies for the treatment of gout.

@en

Adherence with urate-lowering therapies for the treatment of gout.

@nl

prefLabel

Adherence with urate-lowering therapies for the treatment of gout.

@en

Adherence with urate-lowering therapies for the treatment of gout.

@nl

P1433

Q37206942-0129E038-155A-4944-A884-D4CF179BC9F6

P1476

Q37206942-3E2CD28A-908B-43B9-ACF7-931530532EB3

P2093

Q37206942-01A245BF-BCEF-4556-AAD5-A12F037F6B74

Q37206942-42815684-1098-4736-B9F1-57227045FCE5

Q37206942-5FCB62A6-62BA-4FD7-B280-B2FD6063C9BC

Q37206942-6D9A7D9F-7152-450E-B472-5D01E134BE22

Q37206942-765E40DE-AB02-4044-A86A-A79430AFAD29

Q37206942-86B42648-6CD8-491F-BE48-02AFD2A3F3A1

Q37206942-D002A6A0-A9AD-47A1-89DE-B63B1190A3EE

P2860

Q37206942-0DAE541D-81A3-486C-9DE2-220913A9889D

Q37206942-0EB0D66E-C474-4FC1-9EFC-CF2EB3CCC835

Q37206942-1C5FAFCC-FCC9-4179-B190-F84B660705C5

Q37206942-2355CEC6-02C7-47BE-BDDF-11763299832F

Q37206942-2E12BC76-878C-4769-8ED8-C396628641F7

Q37206942-49C2CBBC-328A-49BF-A674-C8D54FCCDF12

Q37206942-645D7C0C-082D-4A07-9146-C878A7FDAC1C

Q37206942-6DF3AB8B-7841-4AC3-B296-AD016672068A

Q37206942-73A0DDC8-5146-4F0F-87B8-F37D50CAB1D7

Q37206942-797C17C9-B871-4DBD-9DE9-1B0A8CC6CD7F

P2888

Q37206942-1211759D-95DC-4D0E-BB78-F12048976049

P304

Q37206942-4078A890-7859-4DED-ACCE-C43B0F360AC4

P31

Q37206942-29D0CCF9-1542-4AFC-862F-D67CAB20BF5A

P356

Q37206942-CD857698-1658-4F11-B4BC-6F70ADEF1679

P433

Q37206942-F43873AB-1D02-4BD1-B257-5B934AA6B79D

P478

Q37206942-050D03B7-8A44-4D5F-82FE-AD279A2124E8

P577

Q37206942-3FE611FC-0CFC-4EC0-B3CC-EB2C56043DBC

P5875

Q37206942-FD0572BF-AD73-42F3-8DDD-36A2233FEAC9

P6179

Q37206942-FDC4D10A-CE01-4961-BCAF-01DD5DD28F4E

P698

Q37206942-AE626C40-8707-405E-BB1E-C00ADDC123B9

P932

Q37206942-35B719E7-A78E-4588-B0F5-C6040F9238B3

P356

P1433

Arthritis Research and Therapy

P1476

Adherence with urate-lowering therapies for the treatment of gout.

@en

P2093

Becky A Briesacher

http://www.w3.org/2001/XMLSchema#string

Hassan Fouayzi

http://www.w3.org/2001/XMLSchema#string

Ira S Ockene

http://www.w3.org/2001/XMLSchema#string

Leslie R Harrold

http://www.w3.org/2001/XMLSchema#string

Marsha A Raebel

http://www.w3.org/2001/XMLSchema#string

Robert A Yood

http://www.w3.org/2001/XMLSchema#string

Susan E Andrade

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of gout

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Adherence to oral hypoglycemic agents in Hawaii.

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Sex differences in gout epidemiology: evaluation and treatment.

Quality of care indicators for gout management.

Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.

Building a research consortium of large health systems: the Cancer Research Network.

Methods for evaluation of medication adherence and persistence using automated databases.

Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.

P2888

P304

R46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2659

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24239673

http://www.w3.org/2001/XMLSchema#string

P6179

1023568855

http://www.w3.org/2001/XMLSchema#string

P698

19327147

http://www.w3.org/2001/XMLSchema#string

P932

2688196

http://www.w3.org/2001/XMLSchema#string